
2026-07-26

HaploX, a global precision multi-omics service provider, announced the launch of the HaploX Multi-Omics Acceleration Program, a worldwide year-end promotion designed to make advanced spatial, single-cell, long-read, proteomic, and metabolomic services more accessible to researchers. Running through December 24, 2026, the program offers substantial savings across seven cutting-edge platforms, including free sequencing on 10x Visium HD spatial transcriptomics from the second sample onward.
HaploX operates a global network of CAP-accredited laboratories and 10x Genomics-authorized service sites, enabling standardized, high-quality multi-omics services for academic institutions, hospitals, biotechnology companies, and pharmaceutical partners around the world. With streamlined logistics, end-to-end project support, and dedicated scientific consultation, HaploX helps customers move from experimental design to publication-ready data with confidence.
The HaploX Multi-Omics Acceleration Program bundles seven services into a single, streamlined promotion, giving researchers the flexibility to choose the right technology for their project while benefiting from significant volume-based savings:
| Products | Promotional Offers |
|---|---|
| 10x Visium HD FFPE 100Gb | Free sequencing from the 2nd sample onward |
| 10x Visium HD FF 210Gb | Free sequencing from the 2nd sample onward |
| 10x 3' Single Cell Transcriptome 100Gb | Free Cell Ranger analysis, data delivery, and logistics/sample collection (>= 2 samples) |
| PB/ONT Long-Read DNA Sequencing | Free one library preparation per cell |
| PB Full-Length Transcriptome Sequencing | Buy 5, Get 1 Free |
| Astral DIA Proteomics | Buy 5, Get 1 Free |
| Untargeted Metabolomics | Buy 5, Get 1 Free |
Notes:
The HaploX Multi-Omics Acceleration Program is open to research institutions, hospitals, biotechnology companies, and pharmaceutical organizations globally. To request a quote, schedule a sample pickup, or discuss your experimental design with our scientific team, contact your HaploX representative or submit your request to customer_service@haplox.net. All offers are valid through December 24, 2026, while slots last and are subject to standard terms and conditions.
HaploX is a global precision multi-omics company dedicated to accelerating scientific discovery and advancing human health. With a comprehensive portfolio spanning genomics, transcriptomics, proteomics, and metabolomics, HaploX provides end-to-end services from experimental design and sample processing to bioinformatics analysis and data interpretation. The company's CAP-accredited laboratories and 10x Genomics-authorized platforms ensure the high standards of data quality and reproducibility for customers worldwide.